Acquisition adds multiple immunology assets to Biogen's portfolio, including a lead asset poised to...
Biogen Expands Immunology Pipeline with Agreement to Acquire RayThera Inc.
Acquisition adds multiple immunology assets to Biogen's portfolio, including a lead asset poised to enter Phase 1 development. CAMBRIDGE, Mass. and SAN...
Author: Biogen
Read Original Article